Karyopharm Therapeutics to Join Baird's Biotech Discovery Series Event
Karyopharm Therapeutics to Join Baird's Biotech Discovery Series
Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a company renowned for its innovative cancer treatments, is preparing to engage in the upcoming Baird's Biotech Discovery Series. This virtual event, scheduled for December 10, 2025, at 12:00 p.m. ET, will feature a fireside chat that includes key insights from Karyopharm's senior management team and the distinguished Dr. Claire Harrison.
About the Event
Dr. Claire Harrison, who is a leading figure in the study of myeloproliferative neoplasms and serves as a Professor at Guy's and St. Thomas' NHS Foundation Trust, will share her expertise during this live discussion. Attendees can access the event through the company's investor website under the
Topics Other）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.